|
Originally published In Press as doi:10.1074/jbc.M603772200 on June 7, 2006
J. Biol. Chem., Vol. 281, Issue 31, 21848-21856, August 4, 2006
Coordinated Regulation of AIB1 Transcriptional Activity by Sumoylation and Phosphorylation*
Huijian Wu,
Luyang Sun,
Ying Zhang,
Yupeng Chen,
Bin Shi,
Ruifang Li,
Yan Wang,
Jing Liang,
Dongwei Fan,
Ge Wu,
Dan Wang,
Shaosi Li, and
Yongfeng Shang1
From the
Department of Biochemistry and Molecular Biology, Peking University Health Science Center, 38 Xue Yuan Road, Beijing 100083, China
AIB1, a member of the steroid receptor coactivator (SRC) family that participates in gene transcriptional activation by nuclear receptors and other transcription factors, is required for animal growth and reproductive development and implicated in breast carcinogenesis. The mechanisms underlying the AIB1 pleiotropic functions are not fully understood and neither is the regulation of its activity. Here, we showed that AIB1 was a sumoylated protein and the sumoylation attenuated the transactivation activity of AIB1, which is in contrast to the sumoylation of its paralogs, GRIP1 and SRC-1. The transactivation activity of AIB1 is enhanced by its phosphorylation by several kinases, including mitogen-activated protein kinase. We demonstrated in this report that estrogen treatment led to an increased phosphorylation and decreased sumoylation of AIB1 and that the sumoylation coordinated with phosphorylation in regulating the transcriptional activity of AIB1, providing a mechanism for post-translational modifications in regulating the transcriptional output of AIB1.
Received for publication, April 19, 2006
, and in revised form, June 5, 2006.
* This work was supported by the National Natural Science Foundation of China (Grants 30225043, 30393110, and 30470912 to Y. S.) and by the Ministry of Science and Technology of China (863 Program Grant 2002BA711A01 and 973 Program Grant 2005CB522404 to Y. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 To whom correspondence should be addressed. Tel.: 86-10-8280-5118; Fax: 86-10-8280-1355; E-mail: yshang{at}hsc.pku.edu.cn.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
G. E Dressing, C. R Hagan, T. P Knutson, A. R Daniel, and C. A Lange
Progesterone receptors act as sensors for mitogenic protein kinases in breast cancer models
Endocr. Relat. Cancer,
June 1, 2009;
16(2):
351 - 361.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. S. Oh, J. T. Lahusen, C. D. Chien, M. P. Fereshteh, X. Zhang, S. Dakshanamurthy, J. Xu, B. L. Kagan, A. Wellstein, and A. T. Riegel
Tyrosine Phosphorylation of the Nuclear Receptor Coactivator AIB1/SRC-3 Is Enhanced by Abl Kinase and Is Required for Its Activity in Cancer Cells
Mol. Cell. Biol.,
November 1, 2008;
28(21):
6580 - 6593.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Narayanan, C. C. Coss, M. Yepuru, J. D. Kearbey, D. D. Miller, and J. T. Dalton
Steroidal Androgens and Nonsteroidal, Tissue-Selective Androgen Receptor Modulator, S-22, Regulate Androgen Receptor Function through Distinct Genomic and Nongenomic Signaling Pathways
Mol. Endocrinol.,
November 1, 2008;
22(11):
2448 - 2465.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. R. Holmstrom, S. Chupreta, A. Y.-L. So, and J. A. Iniguez-Lluhi
SUMO-Mediated Inhibition of Glucocorticoid Receptor Synergistic Activity Depends on Stable Assembly at the Promoter But Not on DAXX
Mol. Endocrinol.,
September 1, 2008;
22(9):
2061 - 2075.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. S. Fenne, T. Hoang, M. Hauglid, J. V. Sagen, E. A. Lien, and G. Mellgren
Recruitment of Coactivator Glucocorticoid Receptor Interacting Protein 1 to an Estrogen Receptor Transcription Complex Is Regulated by the 3',5'-Cyclic Adenosine 5'-Monophosphate-Dependent Protein Kinase
Endocrinology,
September 1, 2008;
149(9):
4336 - 4345.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. M. Miller and S. P. Duckles
Vascular Actions of Estrogens: Functional Implications
Pharmacol. Rev.,
June 1, 2008;
60(2):
210 - 241.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Tremblay, B. J. Wilson, X.-J. Yang, and V. Giguere
Phosphorylation-Dependent Sumoylation Regulates Estrogen-Related Receptor-{alpha} and -{gamma} Transcriptional Activity through a Synergy Control Motif
Mol. Endocrinol.,
March 1, 2008;
22(3):
570 - 584.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. R. Daniel, E. J. Faivre, and C. A. Lange
Phosphorylation-Dependent Antagonism of Sumoylation Derepresses Progesterone Receptor Action in Breast Cancer Cells
Mol. Endocrinol.,
December 1, 2007;
21(12):
2890 - 2906.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Amazit, L. Pasini, A. T. Szafran, V. Berno, R.-C. Wu, M. Mielke, E. D. Jones, M. G. Mancini, C. A. Hinojos, B. W. O'Malley, et al.
Regulation of SRC-3 Intercompartmental Dynamics by Estrogen Receptor and Phosphorylation
Mol. Cell. Biol.,
October 1, 2007;
27(19):
6913 - 6932.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Shi, J. Liang, X. Yang, Y. Wang, Y. Zhao, H. Wu, L. Sun, Y. Zhang, Y. Chen, R. Li, et al.
Integration of Estrogen and Wnt Signaling Circuits by the Polycomb Group Protein EZH2 in Breast Cancer Cells
Mol. Cell. Biol.,
July 15, 2007;
27(14):
5105 - 5119.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|